Background: Fine-needle cytology (FNC) is a useful diagnostic tool in the rst line evaluation of lymphadenopathy of unknown etiology. Due to a lack of standard uniform criteria and reporting systems, the use of FNC in lymph nodes is still not universally acknowledged by clinicians. Aims/objectives: To categorize the lymph node lesions according to Sydney system of reporting the lymph node aspiration cytology cases and assess the risk of malignancy (ROM) for each diagnostic category wherever applicable. Cross sectional retrospective study Study Design: Material and methods: This study was conducted by including all the lymph node aspiration cases over a period of three years. All lymph node cytology the slides were retrieved and reviewed and categorized according to Sydney system of reporting. Corresponding histopathology slides were reviewed and risk of malignancy were calculated. There were 422 lymph node Results: cytology cases. Majority of cases (323) belonged to benign/L2 group followed by L5/malignancy (92 cases), L1/ Non diagnostic (04 cases), L3/ALUS (02 cases) and one case in L4/ suspicious category. By using standardized reporting methods, one can communicate clinically Conclusion: important information in a reproducible manner while limiting interobserver variability
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.